The DOI matches its OpenAlex record; 3 of the 3 references it cites were found in a registry or an index.
Activation of the cAMP Pathway by the TSH Receptor Involves Switching of the Ectodomain from a Tethered Inverse Agonist to an Agonist
Open accessAbstract
Several lines of evidence indicate that constraining intramolecular interactions between transmembrane domains are required to maintain G protein-coupled receptors in an inactive conformation in the absence of agonist. For the glycoprotein hormone receptors, which harbor a long amino-terminal ectodomain responsible for hormone binding, it has been suggested that the ectodomain could contribute to these negative constraints. To test this hypothesis, we expressed at the surface of COS-7 cells mutants of the TSH receptor in which variable portions of the amino-terminal ectodomain are replaced by a 19-residue tag from bovine rhodopsin. Whereas none of the rhodopsin-tagged truncated mutants could be activated by saturating concentrations of TSH, the constructs with the shortest amino-terminal extension displayed increased constitutive activity toward the cAMP pathway, when compared with the wild-type holoreceptor. The shortest truncated construct was strongly activated by the introduction of mutations in transmembrane segment VI (D633A), or in the third intracellular loop (A623I) of the receptor. The magnitude of the stimulation was similar to that observed when the same mutations were introduced in the intact wild-type receptor. On the contrary, the shortest truncated construct was unaffected by activating mutations affecting residues of the extracellular loop region (I486F, I568T) or the top of transmembrane segment VII (del658-661). Together, our results are compatible with a model in which activation of the cAMP pathway by the TSH receptor involves switching of the ectodomain from a tethered inverse agonist to a true agonist.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Crystal Structure of Rhodopsin: A G Protein-Coupled Receptor
Palczewski, K., Kumasaka, T., Hori, T., Behnke, C. A., Motoshima, H., Fox, B. A., Trong, I. L., Teller, D. C., Okada, T., Stenkamp, R. E., et al. (2000) · Science · doi:10.1126/science.289.5480.739 · Cited by 5,637
The Thyrotropin (TSH)-Releasing Hormone Receptor: Interaction with TSH and Autoantibodies*
Rapoport, B., Chazenbalk, G. D., Jaume, J. C., & McLachlan, S. M. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.6.0352 · Cited by 551
Bourne, H. R., & Meng, E. C. (2000) · Science · doi:10.1126/science.289.5480.733 · Cited by 65
Cited by
A molecular dissection of the glycoprotein hormone receptors
Vassart, G. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2004.01.006 · Cited by 343
Self-citationGlycoprotein hormone receptors: link between receptor homodimerization and negative cooperativity
Urizar, E., Montanelli, L., Loy, T., Bonomi, M., Swillens, S., Gales, C., Bouvier, M., Smits, G., Vassart, G., & Costagliola, S. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600686 · Cited by 295
Self-citationOvarian Hyperstimulation Syndrome Due to a Mutation in the Follicle-Stimulating Hormone Receptor
Smits, G., Olatunbosun, O., Delbaere, A., Pierson, R., Vassart, G., & Costagliola, S. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030064 · Cited by 279
Self-citationThyrotropin receptor-associated diseases: from adenomata to Graves disease
Davies, T. F. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26031 · Cited by 262
Activation of Dual Oxidases Duox1 and Duox2
Rigutto, S., Hoste, C., Grasberger, H., Milenkovic, M., Communi, D., Dumont, J. E., Corvilain, B., Miot, F., & De Deken, X. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806893200 · Cited by 213
Metadata
- Authors
- Vlaeminck‐Guillem, V., Ho, S.-C., Rodien, P., Vassart, G., & Costagliola, S.
- Venue
- Molecular Endocrinology
- Publisher
- Oxford University Press
- Published
- 2002-04-01
- Volume
- 16
- Issue
- 4
- Pages
- 736-746
- ISSN
- 0888-8809 (ISSN-L)
- OpenAlex
- W2100479663
- Cited by
- 195
- References
- 3
- FWCI
- 6.16
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.